{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:47:03Z","timestamp":1793447223048,"version":"4.5.0"},"reference-count":280,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,4,1]]},"DOI":"10.1210\/er.2008-0027","type":"journal-article","created":{"date-parts":[[2009,4,3]],"date-time":"2009-04-03T13:29:22Z","timestamp":1238765362000},"page":"152-177","source":"Crossref","is-referenced-by-count":860,"title":["Effects of Growth Hormone on Glucose, Lipid, and Protein Metabolism in Human Subjects"],"prefix":"10.1210","volume":"30","author":[{"given":"Niels","family":"M\u00f8ller","sequence":"first","affiliation":[{"name":"Medical Department M, Aarhus University Hospital, and Clinical Institute, Aarhus University, DK-8000 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Otto Lunde","family":"J\u00f8rgensen","sequence":"additional","affiliation":[{"name":"Medical Department M, Aarhus University Hospital, and Clinical Institute, Aarhus University, DK-8000 Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2019041121352784800_R1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygcen.2005.10.011","article-title":"The dawn and evolution of hormones in the adenohypophysis.","volume":"148","author":"Kawauchi","year":"2006","journal-title":"Gen Comp Endocrinol"},{"key":"2019041121352784800_R2","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.1074\/jbc.R700016200","article-title":"JAK-STAT signaling: from interferons to cytokines.","volume":"282","author":"Schindler","year":"2007","journal-title":"J Biol Chem"},{"key":"2019041121352784800_R3","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1007\/s00125-006-0232-5","article-title":"Proinsulin in development: new roles for an ancient prohormone.","volume":"49","author":"Hernandez-Sanchez","year":"2006","journal-title":"Diabetologia"},{"issue":"Suppl 1","key":"2019041121352784800_R4","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.2337\/diabetes.50.2007.S25","article-title":"Regulation of \u03b2-cell mass by hormones and growth factors","volume":"50","author":"Nielsen","year":"2001","journal-title":"Diabetes"},{"key":"2019041121352784800_R5","first-page":"353","article-title":"Diabetes mellitus: a \u201cthrifty\u201d genotype rendered detrimental by \u201cprogress\u201d?","volume":"14","author":"Neel","year":"1962","journal-title":"Am J Hum Genet"},{"key":"2019041121352784800_R6","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.","volume":"1","author":"Randle","year":"1963","journal-title":"Lancet"},{"key":"2019041121352784800_R7","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/199913a0","article-title":"A metabolic regulating device based on the actions of human growth hormone and of insulin, singly and together, on the human forearm.","volume":"199","author":"Rabinowitz","year":"1963","journal-title":"Nature"},{"key":"2019041121352784800_R8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/edrv-8-2-115","article-title":"Effect of growth hormone on carbohydrate and lipid metabolism.","volume":"8","author":"Davidson","year":"1987","journal-title":"Endocr Rev"},{"key":"2019041121352784800_R9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/dmr.5610040406","article-title":"Growth hormone and metabolism.","volume":"4","author":"Press","year":"1988","journal-title":"Diabetes Metab Rev"},{"key":"2019041121352784800_R10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1210\/edrv-12-4-424","article-title":"Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins.","volume":"12","author":"Baumann","year":"1991","journal-title":"Endocr Rev"},{"key":"2019041121352784800_R11","first-page":"265","article-title":"Growth hormone binding protein. The soluble growth hormone receptor.","volume":"27","author":"Baumann","year":"2002","journal-title":"Minerva Endocrinol"},{"key":"2019041121352784800_R12","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1210\/jc.2008-0375","article-title":"Determination of free growth hormone.","volume":"93","author":"Frystyk","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R13","first-page":"E101","article-title":"Temporal structure of in vivo growth hormone secretory events in humans","volume":"260","author":"Hartman","year":"1991","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R14","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1172\/JCI113450","article-title":"Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man.","volume":"81","author":"Ho","year":"1988","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/jcem-29-6-871","article-title":"Human growth hormone release during sleep: electroencephalographic correlation.","volume":"29","author":"Parker","year":"1969","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R16","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1172\/JCI105893","article-title":"Growth hormone secretion during sleep.","volume":"47","author":"Takahashi","year":"1968","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R17","first-page":"577","article-title":"Secretion of human growth hormone: physiologic and experimental modification.","volume":"12","author":"Roth","year":"1963","journal-title":"Metabolism"},{"key":"2019041121352784800_R18","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2337\/diab.22.8.619","article-title":"Abnormal serum growth hormone response to exercise in maturity-onset diabetics.","volume":"22","author":"Hansen","year":"1973","journal-title":"Diabetes"},{"key":"2019041121352784800_R19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1210\/er.2005-0006","article-title":"Somatotropic and gonadotropic axes linkages in infancy, childhood, and the puberty-adult transition.","volume":"27","author":"Veldhuis","year":"2006","journal-title":"Endocr Rev"},{"key":"2019041121352784800_R20","doi-asserted-by":"crossref","first-page":"4817","DOI":"10.1210\/jc.2002-020517","article-title":"Association between the insulin resistance of puberty and the insulin-like growth factor-I\/growth hormone axis.","volume":"87","author":"Moran","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1210\/edrv-14-1-20","article-title":"Human growth hormone and human aging.","volume":"14","author":"Corpas","year":"1993","journal-title":"Endocr Rev"},{"key":"2019041121352784800_R22","first-page":"E1108","article-title":"Abdominal adiposity rather than age and sex predicts mass and regularity of GH secretion in healthy adults","volume":"272","author":"Vahl","year":"1997","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R23","first-page":"267","article-title":"The effect of recombinant human growth hormone on regulation of growth hormone secretion and blood glucose in insulin-dependent diabetes.","volume":"77","author":"Wurzburger","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.nu.11.070191.002141","article-title":"Nutritional regulation of IGF-I and IGF binding proteins.","volume":"11","author":"Clemmons","year":"1991","journal-title":"Annu Rev Nutr"},{"key":"2019041121352784800_R25","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1172\/JCI116480","article-title":"A low dose euglycemic infusion of recombinant human insulin-like growth factor I rapidly suppresses fasting-enhanced pulsatile growth hormone secretion in humans.","volume":"91","author":"Hartman","year":"1993","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R26","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2265.1994.tb02492.x","article-title":"The effects of recombinant human insulin-like growth factor I on growth hormone secretion in adolescents with insulin dependent diabetes mellitus.","volume":"40","author":"Cheetham","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/edrv.22.1.0419","article-title":"The somatomedin hypothesis: 2001.","volume":"22","author":"Le Roith","year":"2001","journal-title":"Endocr Rev"},{"key":"2019041121352784800_R28","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJM193605142142001","article-title":"The hypophysis and metabolism.","volume":"214","author":"Houssay","year":"1936","journal-title":"N Engl J Med"},{"key":"2019041121352784800_R29","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.7326\/0003-4819-49-5-1090","article-title":"The metabolic effects of human and monkey growth hormone in man.","volume":"49","author":"Beck","year":"1958","journal-title":"Ann Intern Med"},{"key":"2019041121352784800_R30","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0140-6736(58)91141-3","article-title":"The effect of human growth hormone in man.","volume":"1","author":"Ikkos","year":"1958","journal-title":"Lancet"},{"key":"2019041121352784800_R31","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1172\/JCI103824","article-title":"Effect of growth hormone on plasma fatty acids.","volume":"38","author":"Raben","year":"1959","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2337\/diab.23.6.499","article-title":"Acute metabolic effects of human growth hormone.","volume":"23","author":"Fineberg","year":"1974","journal-title":"Diabetes"},{"key":"2019041121352784800_R33","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1172\/JCI105126","article-title":"Effect of human growth hormone on muscle and adipose tissue metabolism in the forearm of man.","volume":"44","author":"Rabinowitz","year":"1965","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R34","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00005792-196311000-00002","article-title":"Roles of insulin and growth hormone, based on studies of forearm metabolism in man.","volume":"42","author":"Zierler","year":"1963","journal-title":"Medicine (Baltimore)"},{"key":"2019041121352784800_R35","doi-asserted-by":"crossref","first-page":"E488","DOI":"10.1152\/ajpendo.00199.2003","article-title":"Additive effects of cortisol and growth hormone on regional and systemic lipolysis in humans","volume":"286","author":"Djurhuus","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121352784800_R36","doi-asserted-by":"crossref","first-page":"E920","DOI":"10.1152\/ajpendo.00374.2006","article-title":"Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics","volume":"292","author":"Krag","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121352784800_R37","doi-asserted-by":"crossref","first-page":"E187","DOI":"10.1152\/ajpendo.90253.2008","article-title":"Stimulation of muscle protein synthesis by somatotropin in pigs is independent of the somatotropin-induced increase in circulating insulin","volume":"295","author":"Wilson","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121352784800_R38","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1210\/jc.2007-2695","article-title":"The effects of growth hormone and\/or testosterone on whole body protein kinetics and skeletal muscle gene expression in healthy elderly men: a randomized controlled trial.","volume":"93","author":"Giannoulis","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R39","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s11154-007-9025-5","article-title":"Recent advances in growth hormone signaling.","volume":"7","author":"Lanning","year":"2006","journal-title":"Rev Endocr Metab Disord"},{"key":"2019041121352784800_R40","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1016\/j.molimm.2006.11.025","article-title":"Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease.","volume":"44","author":"O'Sullivan","year":"2007","journal-title":"Mol Immunol"},{"key":"2019041121352784800_R41","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1210\/edrv-12-3-235","article-title":"The prolactin\/growth hormone receptor family.","volume":"12","author":"Kelly","year":"1991","journal-title":"Endocr Rev"},{"key":"2019041121352784800_R42","doi-asserted-by":"crossref","first-page":"51261","DOI":"10.1074\/jbc.M309486200","article-title":"Mechanisms of growth hormone (GH) action. Identification of conserved Stat5 binding sites that mediate GH-induced insulin-like growth factor-I gene activation.","volume":"278","author":"Woelfle","year":"2003","journal-title":"J Biol Chem"},{"key":"2019041121352784800_R43","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1074\/jbc.R300030200","article-title":"Inhibitors of cytokine signal transduction.","volume":"279","author":"Wormald","year":"2004","journal-title":"J Biol Chem"},{"key":"2019041121352784800_R44","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1210\/endo.143.7.8909","article-title":"GH and epidermal growth factor signaling in normal and Laron syndrome fibroblasts.","volume":"143","author":"Silva","year":"2002","journal-title":"Endocrinology"},{"key":"2019041121352784800_R45","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1210\/jc.2005-0515","article-title":"Severe growth hormone insensitivity resulting from total absence of signal transducer and activator of transcription 5b.","volume":"90","author":"Hwa","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R46","doi-asserted-by":"crossref","first-page":"E899","DOI":"10.1152\/ajpendo.00024.2006","article-title":"Growth hormone receptor signaling in skeletal muscle and adipose tissue in human subjects following exposure to an intravenous GH bolus","volume":"291","author":"Jorgensen","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121352784800_R47","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.ghir.2005.07.001","article-title":"Influence of the crosstalk between growth hormone and insulin signalling on the modulation of insulin sensitivity.","volume":"15","author":"Dominici","year":"2005","journal-title":"Growth Horm IGF Res"},{"key":"2019041121352784800_R48","doi-asserted-by":"crossref","first-page":"15985","DOI":"10.1074\/jbc.275.21.15985","article-title":"SOCS-3 is an insulin-induced negative regulator of insulin signaling.","volume":"275","author":"Emanuelli","year":"2000","journal-title":"J Biol Chem"},{"key":"2019041121352784800_R49","doi-asserted-by":"crossref","first-page":"3471","DOI":"10.1074\/jbc.270.8.3471","article-title":"Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes.","volume":"270","author":"Ridderstrale","year":"1995","journal-title":"J Biol Chem"},{"key":"2019041121352784800_R50","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1210\/endo.140.1.6417","article-title":"Growth hormone stimulates the tyrosine kinase activity of JAK2 and induces tyrosine phosphorylation of insulin receptor substrates and Shc in rat tissues.","volume":"140","author":"Thirone","year":"1999","journal-title":"Endocrinology"},{"key":"2019041121352784800_R51","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/db06-0299","article-title":"Growth hormone regulation of p85\u03b1 expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance.","volume":"56","author":"Rincon","year":"2007","journal-title":"Diabetes"},{"key":"2019041121352784800_R52","doi-asserted-by":"crossref","first-page":"E194","DOI":"10.1152\/ajpendo.00149.2004","article-title":"Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in human skeletal muscle induced by short-term GH infusion","volume":"288","author":"Jessen","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121352784800_R53","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1210\/jc.2006-2659","article-title":"Dose-response effects of free fatty acids on glucose and lipid metabolism during somatostatin blockade of growth hormone and insulin in humans.","volume":"92","author":"Gormsen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R54","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1210\/jc.2007-2414","article-title":"Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background and growth hormone receptor blockade.","volume":"93","author":"Nielsen","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R55","first-page":"E86","article-title":"Effects of a growth hormone pulse on total and forearm substrate fluxes in humans","volume":"258","author":"Moller","year":"1990","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R56","first-page":"E848","article-title":"Effects of a physiological GH pulse on interstitial glycerol in abdominal and femoral adipose tissue","volume":"277","author":"Gravholt","year":"1999","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R57","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1210\/jcem-70-4-1179","article-title":"Short-term effects of growth hormone on fuel oxidation and regional substrate metabolism in normal man.","volume":"70","author":"Moller","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R58","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0026-0495(92)90147-3","article-title":"Dose-response studies on the metabolic effects of a growth hormone pulse in humans.","volume":"41","author":"Moller","year":"1992","journal-title":"Metabolism"},{"key":"2019041121352784800_R59","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1210\/jc.2002-020563","article-title":"Dose dependency of the pharmacokinetics and acute lipolytic actions of growth hormone.","volume":"87","author":"Hansen","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R60","first-page":"E123","article-title":"Effects of pulsatile delivery of basal growth hormone on lipolysis in humans","volume":"271","author":"Cersosimo","year":"1996","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R61","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1371\/journal.pctr.0020021","article-title":"Effects of growth hormone and pioglitazone in viscerally obese adults with impaired glucose tolerance: a factorial clinical trial","volume":"2","author":"Attallah","year":"2007","journal-title":"PLoS Clin Trials"},{"key":"2019041121352784800_R62","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/0026-0495(88)90083-2","article-title":"Nocturnal regulation of free fatty acids in healthy young and elderly men.","volume":"37","author":"Rosenthal","year":"1988","journal-title":"Metabolism"},{"key":"2019041121352784800_R63","first-page":"E168","article-title":"Role of GH in regulating nocturnal rates of lipolysis and plasma mevalonate levels in normal and diabetic humans","volume":"263","author":"Boyle","year":"1992","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R64","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1365-2265.2000.00862.x","article-title":"The effects of growth hormone replacement therapy on overnight metabolic fuels in hypopituitary patients.","volume":"52","author":"Kousta","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R65","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1210\/jcem-70-1-207","article-title":"Evening versus morning injections of growth hormone (GH) in GH-deficient patients: effects on 24-hour patterns of circulating hormones and metabolites.","volume":"70","author":"Jorgensen","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R66","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2337\/diacare.16.7.1011","article-title":"Evidence for a role for insulin and growth hormone in overnight regulation of 3-hydroxybutyrate in normal and diabetic adolescents.","volume":"16","author":"Edge","year":"1993","journal-title":"Diabetes Care"},{"key":"2019041121352784800_R67","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s001250050789","article-title":"A circadian rhythm in lipid mobilization which is altered in IDDM.","volume":"40","author":"Hagstrom-Toft","year":"1997","journal-title":"Diabetologia"},{"key":"2019041121352784800_R68","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1210\/jcem.87.8.8774","article-title":"Hyposomatotropism blunts lipolysis in abdominally obese women.","volume":"87","author":"Buijs","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R69","doi-asserted-by":"crossref","first-page":"3612","DOI":"10.1210\/jcem.82.11.4388","article-title":"Metabolic effects and pharmacokinetics of a growth hormone pulse in healthy adults: relation to age, sex, and body composition.","volume":"82","author":"Vahl","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R70","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1042\/bj2580547","article-title":"Regulation of fatty acid and carbohydrate metabolism by insulin, growth hormone and tri-iodothyronine in hepatocyte cultures from normal and hypophysectomized rats.","volume":"258","author":"Betley","year":"1989","journal-title":"Biochem J"},{"key":"2019041121352784800_R71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/bj2740021","article-title":"Regulation of fatty acid metabolism and gluconeogenesis by growth hormone and insulin in sheep hepatocyte cultures. Effects of lactation and pregnancy.","volume":"274","author":"Emmison","year":"1991","journal-title":"Biochem J"},{"key":"2019041121352784800_R72","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00281115","article-title":"Effect of physiological elevation of plasma growth hormone levels on ketone body kinetics and lipolysis in normal and acutely insulin-deficient man.","volume":"26","author":"Keller","year":"1984","journal-title":"Diabetologia"},{"key":"2019041121352784800_R73","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.domaniend.2004.06.004","article-title":"Regulation of development and metabolism of adipose tissue by growth hormone and the insulin-like growth factor system.","volume":"27","author":"Louveau","year":"2004","journal-title":"Domest Anim Endocrinol"},{"key":"2019041121352784800_R74","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/bj3310815","article-title":"Somatotropin-dependent decrease in fatty acid synthase mRNA abundance in 3T3\u2013F442A adipocytes is the result of a decrease in both gene transcription and mRNA stability.","volume":"331","author":"Yin","year":"1998","journal-title":"Biochem J"},{"key":"2019041121352784800_R75","doi-asserted-by":"crossref","first-page":"E467","DOI":"10.1152\/ajpendo.1992.263.3.E467","article-title":"Effect of long-term rhGH administration in GH-deficient adults on fat cell epinephrine response","volume":"263","author":"Beauville","year":"1992","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121352784800_R76","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.2337\/diabetes.50.10.2301","article-title":"Pharmacological antilipolysis restores insulin sensitivity during growth hormone exposure.","volume":"50","author":"Nielsen","year":"2001","journal-title":"Diabetes"},{"key":"2019041121352784800_R77","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1530\/eje.0.1500779","article-title":"Modulation of basal glucose metabolism and insulin sensitivity by growth hormone and free fatty acids during short-term fasting.","volume":"150","author":"Norrelund","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"2019041121352784800_R78","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1210\/jcem.86.12.8096","article-title":"Inhibition of the rise in FFA by acipimox partially prevents GH-induced insulin resistance in GH-deficient adults.","volume":"86","author":"Segerlantz","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R79","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1210\/jcem.84.5.5685","article-title":"Mediation of the hepatic effects of growth hormone by its lipolytic activity.","volume":"84","author":"Piatti","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R80","first-page":"4208","article-title":"Stimulation of mitochondrial fatty acid oxidation by growth hormone in human fibroblasts.","volume":"82","author":"Leung","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R81","first-page":"10","article-title":"Effect of growth hormone on adipose tissue and skeletal muscle lipoprotein lipase activity in humans.","volume":"22","author":"Richelsen","year":"1999","journal-title":"J Endocrinol Invest"},{"key":"2019041121352784800_R82","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1053\/meta.2000.6738","article-title":"Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients.","volume":"49","author":"Richelsen","year":"2000","journal-title":"Metabolism"},{"key":"2019041121352784800_R83","first-page":"936","article-title":"Growth hormone inhibits lipoprotein lipase activity in human adipose tissue.","volume":"80","author":"Ottosson","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R84","first-page":"4172","article-title":"Modulation of 11\u03b2-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies.","volume":"84","author":"Moore","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R85","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1210\/jc.2005-1694","article-title":"Growth hormone (GH) substitution in GH-deficient patients inhibits 11\u03b2-hydroxysteroid dehydrogenase type 1 messenger ribonucleic acid expression in adipose tissue.","volume":"91","author":"Paulsen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R86","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI108486","article-title":"Free fatty acid oxidation by forearm muscle at rest, and evidence for an intramuscular lipid pool in the human forearm.","volume":"58","author":"Dagenais","year":"1976","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R87","first-page":"167","article-title":"Free fatty acid metabolism in the forearm at rest: muscle uptake and adipose tissue release of free fatty acids.","volume":"138","author":"Tancredi","year":"1976","journal-title":"Johns Hopkins Med J"},{"key":"2019041121352784800_R88","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1152\/jappl.1983.55.2.628","article-title":"Calculation of substrate oxidation rates in vivo from gaseous exchange.","volume":"55","author":"Frayn","year":"1983","journal-title":"J Appl Physiol"},{"key":"2019041121352784800_R89","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/acta.0.0860803","article-title":"Influence of growth hormone on splanchnic glucose production in man.","volume":"86","author":"Adamson","year":"1977","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041121352784800_R90","first-page":"F474","article-title":"Growth hormone stimulates IGF I gene expression in isolated rat renal collecting duct","volume":"259","author":"Rogers","year":"1990","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R91","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2337\/diabetes.50.4.747","article-title":"Assessment of postabsorptive renal glucose metabolism in humans with multiple glucose tracers.","volume":"50","author":"Moller","year":"2001","journal-title":"Diabetes"},{"key":"2019041121352784800_R92","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1172\/JCI106016","article-title":"Liver and kidney metabolism during prolonged starvation.","volume":"48","author":"Owen","year":"1969","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R93","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/BF00873216","article-title":"Increased glucose turnover and glucose cycling in acromegalic patients with normal glucose tolerance.","volume":"29","author":"Karlander","year":"1986","journal-title":"Diabetologia"},{"key":"2019041121352784800_R94","first-page":"E513","article-title":"Mechanism of growth hormone-induced postprandial carbohydrate intolerance in humans","volume":"260","author":"Butler","year":"1991","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R95","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1749-6632.1968.tb20368.x","article-title":"The effects of growth hormone on carbohydrate and lipid metabolism in the dog.","volume":"148","author":"Altszuler","year":"1968","journal-title":"Ann NY Acad Sci"},{"key":"2019041121352784800_R96","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1210\/jcem.87.2.8391","article-title":"Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation.","volume":"87","author":"Schwarz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R97","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2337\/diabetes.52.2.260","article-title":"Effects of free fatty acids per se on glucose production, gluconeogenesis, and glycogenolysis.","volume":"52","author":"Staehr","year":"2003","journal-title":"Diabetes"},{"key":"2019041121352784800_R98","doi-asserted-by":"crossref","first-page":"50","DOI":"10.2337\/db07-0694","article-title":"Evidence that processes other than gluconeogenesis may influence the ratio of deuterium on the fifth and third carbons of glucose: implications for the use of 2H2O to measure gluconeogenesis in humans.","volume":"57","author":"Bock","year":"2008","journal-title":"Diabetes"},{"key":"2019041121352784800_R99","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2337\/diab.41.4.424","article-title":"Growth hormone stimulates skeletal muscle protein synthesis and antagonizes insulin\u2019s antiproteolytic action in humans.","volume":"41","author":"Fryburg","year":"1992","journal-title":"Diabetes"},{"key":"2019041121352784800_R100","first-page":"E499","article-title":"Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans","volume":"260","author":"Fryburg","year":"1991","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R101","first-page":"1040","article-title":"Acute growth hormone effects on amino acid and lipid metabolism.","volume":"78","author":"Copeland","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R102","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1096-6374(02)00119-3","article-title":"Effects of lowering circulating free fatty acid levels on protein metabolism in adult growth hormone deficient patients.","volume":"12","author":"Nielsen","year":"2002","journal-title":"Growth Horm IGF Res"},{"key":"2019041121352784800_R103","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/0026-0495(93)90285-V","article-title":"Growth hormone acutely stimulates skeletal muscle but not whole-body protein synthesis in humans.","volume":"42","author":"Fryburg","year":"1993","journal-title":"Metabolism"},{"key":"2019041121352784800_R104","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1172\/JCI114694","article-title":"Human growth hormone prevents the protein catabolic side effects of prednisone in humans.","volume":"86","author":"Horber","year":"1990","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R105","first-page":"E261","article-title":"Effect of growth hormone and resistance exercise on muscle growth in young men","volume":"262","author":"Yarasheski","year":"1992","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R106","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0899-9007(98)00166-X","article-title":"Muscle amino acid metabolism and the control of muscle protein turnover in patients with chronic renal failure.","volume":"15","author":"Garibotto","year":"1999","journal-title":"Nutrition"},{"key":"2019041121352784800_R107","first-page":"E840","article-title":"Growth hormone administration in older adults: effects on albumin synthesis","volume":"266","author":"Zachwieja","year":"1994","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R108","first-page":"4344","article-title":"How is whole body protein turnover perturbed in growth hormone-deficient adults?","volume":"83","author":"Hoffman","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R109","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1530\/acta.0.1290158","article-title":"Whole-body leucine turnover in adults on conventional treatment for hypopituitarism.","volume":"129","author":"Beshyah","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041121352784800_R110","first-page":"E959","article-title":"Growth hormone effects on hepatic glutamate handling in vivo","volume":"257","author":"Welbourne","year":"1989","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R111","first-page":"1220","article-title":"Effects of growth hormone (GH) administration on functional hepatic nitrogen clearance: studies in normal subjects and GH-deficient patients.","volume":"78","author":"Wolthers","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R112","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0168-8278(96)80010-9","article-title":"Effects of long-term growth hormone (GH) and triiodothyronine (T3) administration on functional hepatic nitrogen clearance in normal man.","volume":"24","author":"Wolthers","year":"1996","journal-title":"J Hepatol"},{"key":"2019041121352784800_R113","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1210\/jcem-29-1-119","article-title":"Calorigenic effect of human growth hormone in obesity.","volume":"29","author":"Bray","year":"1969","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R114","first-page":"1416","article-title":"Calorigenic effects of growth hormone: the role of thyroid hormones.","volume":"81","author":"Wolthers","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R115","first-page":"E736","article-title":"Effects of growth hormone on fuel utilization and muscle glycogen synthase activity in normal humans","volume":"260","author":"Bak","year":"1991","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R116","first-page":"1589","article-title":"Marked effects of sustained low growth hormone (GH) levels on day-to-day fuel metabolism: studies in GH-deficient patients and healthy untreated subjects.","volume":"77","author":"Jorgensen","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R117","first-page":"1255","article-title":"Diurnal variations in twenty-four-hour energy expenditure during growth hormone treatment of adults with pituitary deficiency.","volume":"82","author":"Stenlof","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R118","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1172\/JCI117427","article-title":"Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans.","volume":"94","author":"Hussain","year":"1994","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R119","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1210\/jcem-69-6-1127","article-title":"Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxine-substituted central hypothyroidism.","volume":"69","author":"Jorgensen","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R120","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2265.1994.tb01826.x","article-title":"Growth hormone administration stimulates energy expenditure and extrathyroidal conversion of thyroxine to triiodothyronine in a dose-dependent manner and suppresses circadian thyrotrophin levels: studies in GH-deficient adults.","volume":"41","author":"Jorgensen","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R121","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1210\/jc.2007-1814","article-title":"Enhancement of muscle mitochondrial function by growth hormone.","volume":"93","author":"Short","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R122","first-page":"4073","article-title":"Regulation of uncoupling protein-2 and -3 by growth hormone in skeletal muscle and adipose tissue in growth hormone-deficient adults.","volume":"84","author":"Pedersen","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R123","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1111\/j.1365-2265.1994.tb01827.x","article-title":"Short and long-term cardiovascular effects of growth hormone therapy in growth hormone deficient adults.","volume":"41","author":"Thuesen","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R124","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1172\/JCI119095","article-title":"Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. A double-blind, placebo-controlled study.","volume":"98","author":"Boger","year":"1996","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R125","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effects of growth hormone treatment in GH-deficient adults.","volume":"1","author":"Jorgensen","year":"1989","journal-title":"Lancet"},{"key":"2019041121352784800_R126","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJM197003192821209","article-title":"Starvation in man.","volume":"282","author":"Cahill Jr","year":"1970","journal-title":"N Engl J Med"},{"key":"2019041121352784800_R127","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1172\/JCI112785","article-title":"Lipolysis during fasting. Decreased suppression by insulin and increased stimulation by epinephrine.","volume":"79","author":"Jensen","year":"1987","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R128","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1172\/JCI106639","article-title":"Human forearm metabolism during progressive starvation.","volume":"50","author":"Owen","year":"1971","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R129","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/ajcn\/68.1.12","article-title":"Protein, fat, and carbohydrate requirements during starvation: anaplerosis and cataplerosis.","volume":"68","author":"Owen","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"2019041121352784800_R130","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1748-1716.2007.01740.x","article-title":"Effects of a 3-day fast on regional lipid and glucose metabolism in human skeletal muscle and adipose tissue.","volume":"191","author":"Gjedsted","year":"2007","journal-title":"Acta Physiol (Oxf)"},{"key":"2019041121352784800_R131","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI104138","article-title":"Effects of human growth hormone in man.","volume":"39","author":"Henneman","year":"1960","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R132","first-page":"188","article-title":"Positive nitrogen balance with human growth hormone and hypocaloric intravenous feeding.","volume":"100","author":"Manson","year":"1986","journal-title":"Surgery"},{"key":"2019041121352784800_R133","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0026-0495(91)90116-E","article-title":"Growth hormone improves muscle protein metabolism and whole body nitrogen economy in man during a hyponitrogenous diet.","volume":"40","author":"Lundeberg","year":"1991","journal-title":"Metabolism"},{"key":"2019041121352784800_R134","first-page":"3120","article-title":"Continuation of growth hormone (GH) substitution during fasting in GH-deficient patients decreases urea excretion and conserves protein synthesis.","volume":"86","author":"Norrelund","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R135","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2337\/diabetes.50.1.96","article-title":"The protein-retaining effects of growth hormone during fasting involve inhibition of muscle-protein breakdown.","volume":"50","author":"Norrelund","year":"2001","journal-title":"Diabetes"},{"key":"2019041121352784800_R136","doi-asserted-by":"crossref","first-page":"E737","DOI":"10.1152\/ajpendo.00092.2003","article-title":"Effects of GH on urea, glucose and lipid metabolism, and insulin sensitivity during fasting in GH-deficient patients","volume":"285","author":"Norrelund","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121352784800_R137","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1210\/jcem-72-1-51","article-title":"Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man.","volume":"72","author":"Veldhuis","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R138","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1172\/JCI106508","article-title":"Metabolic response to human growth hormone during prolonged starvation.","volume":"50","author":"Felig","year":"1971","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R139","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1210\/jcem-64-5-878","article-title":"Growth hormone administration conserves lean body mass during dietary restriction in obese subjects.","volume":"64","author":"Clemmons","year":"1987","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R140","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1210\/jcem-67-1-54","article-title":"Treatment of obese, diet-restricted subjects with growth hormone for 11 weeks: effects on anabolism, lipolysis, and body composition.","volume":"67","author":"Snyder","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R141","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1046\/j.1365-2265.2000.00937.x","article-title":"Effects of growth hormone administration on protein dynamics and substrate metabolism during 4 weeks of dietary restriction in obese women.","volume":"52","author":"Norrelund","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R142","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1210\/jc.2003-030267","article-title":"The decisive role of free fatty acids for protein conservation during fasting in humans with and without growth hormone.","volume":"88","author":"Norrelund","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R143","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1210\/jc.2008-0079","article-title":"Role of growth hormone in regulating lipolysis, proteolysis, and hepatic glucose production during fasting.","volume":"93","author":"Sakharova","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R144","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1172\/JCI113570","article-title":"Effect of \u03b2-hydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humans.","volume":"82","author":"Nair","year":"1988","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R145","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1172\/JCI108057","article-title":"Effect of ketone infusions on amino acid and nitrogen metabolism in man.","volume":"55","author":"Sherwin","year":"1975","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R146","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1172\/JCI112339","article-title":"Inverse relationship of leucine flux and oxidation to free fatty acid availability in vivo.","volume":"77","author":"Tessari","year":"1986","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R147","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1210\/er.2006-0052","article-title":"The growth hormone\/insulin-like growth factor-I axis in exercise and sport.","volume":"28","author":"Gibney","year":"2007","journal-title":"Endocr Rev"},{"key":"2019041121352784800_R148","doi-asserted-by":"crossref","first-page":"747","DOI":"10.7326\/0003-4819-148-10-200805200-00215","article-title":"Systematic review: the effects of growth hormone on athletic performance.","volume":"148","author":"Liu","year":"2008","journal-title":"Ann Intern Med"},{"key":"2019041121352784800_R149","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1530\/acta.0.1070295","article-title":"Characterization of growth hormone release in response to external heating. Comparison to exercise induced release.","volume":"107","author":"Christensen","year":"1984","journal-title":"Acta Endocrinol (Copenh)"},{"key":"2019041121352784800_R150","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ghir.2006.02.005","article-title":"Exercising in the cold inhibits growth hormone secretion by reducing the rise in core body temperature.","volume":"16","author":"Wheldon","year":"2006","journal-title":"Growth Horm IGF Res"},{"key":"2019041121352784800_R151","first-page":"3335","article-title":"Growth hormone deficiency and hyperthermia during exercise: a controlled study of sixteen GH-deficient patients.","volume":"80","author":"Juul","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R152","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/japplphysiol.00711.2003","article-title":"Acute exposure to GH during exercise stimulates the turnover of free fatty acids in GH-deficient men.","volume":"96","author":"Kanaley","year":"2004","journal-title":"J Appl Physiol"},{"key":"2019041121352784800_R153","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.ghir.2005.08.003","article-title":"GH secretion in acute exercise may result in post-exercise lipolysis.","volume":"15","author":"Wee","year":"2005","journal-title":"Growth Horm IGF Res"},{"key":"2019041121352784800_R154","doi-asserted-by":"crossref","first-page":"E989","DOI":"10.1152\/ajpendo.2000.279.5.E989","article-title":"Growth hormone enhances effects of endurance training on oxidative muscle metabolism in elderly women","volume":"279","author":"Lange","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121352784800_R155","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1210\/jc.2002-021872","article-title":"High dose growth hormone exerts an anabolic effect at rest and during exercise in endurance-trained athletes.","volume":"88","author":"Healy","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R156","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jc.2005-0916","article-title":"Effects of high-dose growth hormone on glucose and glycerol metabolism at rest and during exercise in endurance-trained athletes.","volume":"91","author":"Healy","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R157","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1113\/jphysiol.2005.089524","article-title":"No effect of growth hormone administration on substrate oxidation during exercise in young, lean men.","volume":"567","author":"Hansen","year":"2005","journal-title":"J Physiol"},{"key":"2019041121352784800_R158","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.1210\/jc.2001-011797","article-title":"Acute growth hormone administration causes exaggerated increases in plasma lactate and glycerol during moderate to high intensity bicycling in trained young men.","volume":"87","author":"Lange","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R159","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1210\/jc.2002-020540","article-title":"Effect of growth hormone (GH) on glycerol and free fatty acid metabolism during exhaustive exercise in GH-deficient adults.","volume":"88","author":"Gibney","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R160","first-page":"590","article-title":"The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.","volume":"82","author":"Van den Berghe","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R161","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1210\/jc.2007-1194","article-title":"Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans.","volume":"92","author":"Vila","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R162","doi-asserted-by":"crossref","first-page":"E823","DOI":"10.1152\/ajpendo.00020.2002","article-title":"Insulin action on protein metabolism in acromegalic patients","volume":"284","author":"Battezzati","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121352784800_R163","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1210\/jc.2007-2780","article-title":"Lower visceral and subcutaneous but higher intermuscular adipose tissue depots in patients with GH and IGF-I excess due to acromegaly.","volume":"93","author":"Freda","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R164","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1210\/jc.2006-0664","article-title":"Protein metabolism in acromegaly: differential effects of short- and long-term treatment.","volume":"92","author":"Gibney","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R165","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2265.1994.tb02552.x","article-title":"Body composition in active acromegaly during treatment with octreotide: a double-blind, placebo-controlled cross-over study.","volume":"41","author":"Hansen","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R166","first-page":"1012","article-title":"Basal- and insulin-stimulated substrate metabolism in patients with active acromegaly before and after adenomectomy.","volume":"74","author":"Moller","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R167","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1172\/JCI119747","article-title":"Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease.","volume":"100","author":"McNurlan","year":"1997","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R168","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJM199909093411102","article-title":"Increased mortality associated with growth hormone treatment in critically ill adults.","volume":"341","author":"Takala","year":"1999","journal-title":"N Engl J Med"},{"key":"2019041121352784800_R169","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in the critically ill patients.","volume":"345","author":"Van den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"2019041121352784800_R170","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00505182","article-title":"Effects of growth hormone on insulin sensitivity and forearm metabolism in normal man.","volume":"32","author":"Moller","year":"1989","journal-title":"Diabetologia"},{"key":"2019041121352784800_R171","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1210\/jc.2002-020542","article-title":"Growth hormone replacement therapy induces insulin resistance by activating the glucose-fatty acid cycle.","volume":"88","author":"Bramnert","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R172","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1172\/JCI118742","article-title":"Mechanism of free fatty acid-induced insulin resistance in humans.","volume":"97","author":"Roden","year":"1996","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R173","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2337\/diabetes.51.7.2005","article-title":"Lipid-induced insulin resistance in human muscle is associated with changes in diacylglycerol, protein kinase C, and I\u03baB-\u03b1.","volume":"51","author":"Itani","year":"2002","journal-title":"Diabetes"},{"key":"2019041121352784800_R174","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/diabetes.48.6.1270","article-title":"Free fatty acid-induced insulin resistance is associated with activation of protein kinase C \u03b8 and alterations in the insulin signaling cascade.","volume":"48","author":"Griffin","year":"1999","journal-title":"Diabetes"},{"key":"2019041121352784800_R175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1152\/physiol.00007.2004","article-title":"Unraveling the cellular mechanism of insulin resistance in humans: new insights from magnetic resonance spectroscopy.","volume":"19","author":"Shulman","year":"2004","journal-title":"Physiology"},{"key":"2019041121352784800_R176","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/BF00425888","article-title":"Diurnal patterns of blood glucose, serum free fatty acids, insulin, glucagon and growth hormone in normals and juvenile diabetics.","volume":"6","author":"Hansen","year":"1970","journal-title":"Diabetologia"},{"key":"2019041121352784800_R177","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1210\/jcem-69-2-239","article-title":"Alterations in the pulsatile mode of growth hormone release in men and women with insulin-dependent diabetes mellitus.","volume":"69","author":"Asplin","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R178","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2337\/diab.33.12.1175","article-title":"Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes.","volume":"33","author":"Amiel","year":"1984","journal-title":"Diabetes"},{"key":"2019041121352784800_R179","first-page":"E846","article-title":"Insulin regulates insulin-like growth factor I mRNA in rat hepatocytes","volume":"260","author":"Boni-Schnetzler","year":"1991","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R180","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1677\/jme.0.0090257","article-title":"Intraperitoneal insulin is more potent than subcutaneous insulin at restoring hepatic insulin-like growth factor-I mRNA levels in the diabetic rat: a functional role for the portal vascular link.","volume":"9","author":"Russell-Jones","year":"1992","journal-title":"J Mol Endocrinol"},{"key":"2019041121352784800_R181","first-page":"E395","article-title":"Growth hormone, cortisol, or both are involved in defense against, but are not critical to recovery from, hypoglycemia","volume":"260","author":"Boyle","year":"1991","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R182","first-page":"E835","article-title":"Demonstration of a role for growth hormone in glucose counterregulation","volume":"256","author":"De Feo","year":"1989","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R183","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.2337\/diabetes.54.12.3592","article-title":"Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes.","volume":"54","author":"Cryer","year":"2005","journal-title":"Diabetes"},{"key":"2019041121352784800_R184","first-page":"432","article-title":"Effects of a physiological growth hormone pulse on substrate metabolism in insulin-dependent (type 1) diabetic subjects.","volume":"75","author":"Moller","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R185","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1046\/j.1365-2265.2003.01714.x","article-title":"The effect of growth hormone (GH) replacement therapy in adult patients with type 1 diabetes mellitus and GH deficiency.","volume":"58","author":"Christ","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R186","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJM198403293101302","article-title":"Importance of raised growth hormone levels in mediating the metabolic derangements of diabetes.","volume":"310","author":"Press","year":"1984","journal-title":"N Engl J Med"},{"key":"2019041121352784800_R187","first-page":"1518","article-title":"The combination of insulin-like growth factor I and insulin-like growth factor-binding protein-3 reduces insulin requirements in insulin-dependent type 1 diabetes: evidence for in vivo biological activity.","volume":"85","author":"Clemmons","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R188","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1210\/jcem-55-5-973","article-title":"The effect of growth hormone on glucose metabolism and insulin secretion in man.","volume":"55","author":"Bratusch-Marrain","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R189","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2337\/diab.31.8.663","article-title":"Effects of growth hormone on insulin action in man. Mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization.","volume":"31","author":"Rizza","year":"1982","journal-title":"Diabetes"},{"key":"2019041121352784800_R190","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/jcem-68-2-276","article-title":"Influence of growth hormone on glucose-induced glucose uptake in normal men as assessed by the hyperglycemic clamp technique.","volume":"68","author":"Orskov","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R191","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/BF00403286","article-title":"Characterization of the insulin-antagonistic effect of growth hormone in man.","volume":"34","author":"Fowelin","year":"1991","journal-title":"Diabetologia"},{"key":"2019041121352784800_R192","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/jama.1965.03080110069026","article-title":"High growth-hormone levels in diabetic ketoacidosis: a possible cause of insulin resistance.","volume":"191","author":"Unger","year":"1965","journal-title":"JAMA"},{"key":"2019041121352784800_R193","doi-asserted-by":"crossref","first-page":"916","DOI":"10.2337\/diab.27.9.916","article-title":"The regulation of plasma ketone body concentration by counter-regulatory hormones in man. II. Effects of growth hormone in diabetic man.","volume":"27","author":"Schade","year":"1978","journal-title":"Diabetes"},{"key":"2019041121352784800_R194","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1056\/NEJM198506063122302","article-title":"Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.","volume":"312","author":"Campbell","year":"1985","journal-title":"N Engl J Med"},{"key":"2019041121352784800_R195","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF00586461","article-title":"Nocturnal spikes of growth hormone secretion cause the dawn phenomenon in type 1 (insulin-dependent) diabetes mellitus by decreasing hepatic (and extrahepatic) sensitivity to insulin in the absence of insulin waning.","volume":"33","author":"Perriello","year":"1990","journal-title":"Diabetologia"},{"key":"2019041121352784800_R196","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2337\/diab.38.3.273","article-title":"Morning insulin requirements. Critique of dawn and meal phenomena.","volume":"38","author":"Blackard","year":"1989","journal-title":"Diabetes"},{"key":"2019041121352784800_R197","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s001250051031","article-title":"Failure of nocturnal changes in growth hormone to alter carbohydrate tolerance the following morning.","volume":"41","author":"Nielsen","year":"1998","journal-title":"Diabetologia"},{"key":"2019041121352784800_R198","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1172\/JCI115396","article-title":"Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep.","volume":"88","author":"Van Cauter","year":"1991","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R199","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2337\/diab.38.3.285","article-title":"Sleep-associated fall in glucose disposal and hepatic glucose output in normal humans. Putative signaling mechanism linking peripheral and hepatic events.","volume":"38","author":"Clore","year":"1989","journal-title":"Diabetes"},{"key":"2019041121352784800_R200","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2265.2005.02359.x","article-title":"Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.","volume":"63","author":"Yuen","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R201","first-page":"918","article-title":"Hypoglycemia in hypopituitary children.","volume":"129","author":"Hopwood","year":"1975","journal-title":"Am J Dis Child"},{"key":"2019041121352784800_R202","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1210\/jcem-61-6-1152","article-title":"Effects of hypopituitarism and growth hormone replacement therapy on the production and utilization of glucose in childhood.","volume":"61","author":"Bougneres","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R203","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/cs0890321","article-title":"\u03b2-Cell function in hypopituitary adults before and during growth hormone treatment.","volume":"89","author":"Beshyah","year":"1995","journal-title":"Clin Sci (Lond)"},{"key":"2019041121352784800_R204","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/0026-0495(95)90004-7","article-title":"Growth hormone-deficient adults are insulin-resistant.","volume":"44","author":"Johansson","year":"1995","journal-title":"Metabolism"},{"key":"2019041121352784800_R205","first-page":"555","article-title":"Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity.","volume":"81","author":"Hew","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R206","first-page":"2209","article-title":"Abdominal adiposity and physical fitness are major determinants of the age associated decline in stimulated GH secretion in healthy adults.","volume":"81","author":"Vahl","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R207","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/0026-0495(93)90197-V","article-title":"Effects of treatment with recombinant human growth hormone on insulin sensitivity and glucose metabolism in adults with growth hormone deficiency.","volume":"42","author":"Fowelin","year":"1993","journal-title":"Metabolism"},{"key":"2019041121352784800_R208","first-page":"975","article-title":"The effect of 3 months of recombinant human growth hormone (GH) therapy on insulin and glucose-mediated glucose disposal and insulin secretion in GH-deficient adults: a minimal model analysis.","volume":"79","author":"O'Neal","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R209","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1054\/ghir.1999.0091","article-title":"The effect of the deterioration of insulin sensitivity on \u03b2-cell function in growth-hormone-deficient adults following 4-month growth hormone replacement therapy.","volume":"9","author":"Rosenfalck","year":"1999","journal-title":"Growth Horm IGF Res"},{"key":"2019041121352784800_R210","first-page":"356","article-title":"The effects of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance.","volume":"80","author":"Beshyah","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R211","first-page":"3285","article-title":"Growth hormone (GH) replacement reduces total body fat and normalizes insulin sensitivity in GH-deficient adults: a report of one-year clinical experience.","volume":"82","author":"Hwu","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R212","first-page":"153","article-title":"The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults.","volume":"80","author":"Weaver","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R213","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1365-2265.1999.00595.x","article-title":"A low individualized GH dose in young patients with childhood onset GH deficiency normalized serum IGF-I without significant deterioration in glucose tolerance.","volume":"50","author":"Bulow","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R214","first-page":"1668","article-title":"Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.","volume":"83","author":"Christopher","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R215","doi-asserted-by":"crossref","first-page":"4173","DOI":"10.1210\/jcem.85.11.6930","article-title":"The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.","volume":"85","author":"Rosenfalck","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R216","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1046\/j.1365-2265.1998.00460.x","article-title":"Effects of four years\u2019 treatment with biosynthetic human growth hormone (GH) on glucose homeostasis, insulin secretion and lipid metabolism in GH-deficient adults.","volume":"48","author":"Shoumer","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R217","first-page":"281","article-title":"Substrate metabolism and insulin sensitivity following long-term growth hormone (GH) replacement therapy in GH-deficient adults.","volume":"3","author":"Jorgensen","year":"1996","journal-title":"Endocrinol Metab"},{"key":"2019041121352784800_R218","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1210\/jcem.87.5.8482","article-title":"Effects of seven years of GH-replacement therapy on insulin sensitivity in GH-deficient adults.","volume":"87","author":"Svensson","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R219","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1210\/jcem.84.8.5916","article-title":"The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients.","volume":"84","author":"Gibney","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R220","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1210\/jcem.85.2.6403","article-title":"Growth hormone replacement therapy is not associated with retinal changes.","volume":"85","author":"Blank","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R221","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1046\/j.1365-2265.2002.01517.x","article-title":"Reduced capillary permeability and capillary density in the skin of GH-deficient adults: improvement after 12 months GH replacement.","volume":"56","author":"Oomen","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R222","first-page":"4516","article-title":"Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children.","volume":"84","author":"Johannsson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R223","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1210\/jcem.85.5.6613","article-title":"Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism.","volume":"85","author":"Norrelund","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R224","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1210\/jc.2003-031588","article-title":"Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.","volume":"89","author":"Carroll","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R225","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1046\/j.1365-2265.1996.8720883.x","article-title":"Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.","volume":"45","author":"Jorgensen","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R226","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2003-030840","article-title":"Impact of growth hormone (GH) treatment on cardiovascular risk factors in GH-deficient adults: a metaanalysis of blinded, randomized, placebo-controlled trials.","volume":"89","author":"Maison","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R227","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1210\/jcem.83.2.4545","article-title":"A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults.","volume":"83","author":"Lucidi","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R228","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2265.1993.tb00525.x","article-title":"The effects of growth hormone on protein metabolism in adult growth hormone deficient patients.","volume":"38","author":"Russell-Jones","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R229","doi-asserted-by":"crossref","first-page":"5827","DOI":"10.1210\/jc.2002-021943","article-title":"Short- and long-term effects of growth hormone (GH) replacement on protein metabolism in GH-deficient adults.","volume":"88","author":"Shi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R230","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1365-2265.1992.tb02287.x","article-title":"The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition.","volume":"37","author":"Binnerts","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R231","first-page":"E1050","article-title":"Effect of growth hormone treatment on postprandial protein metabolism in growth hormone-deficient adults","volume":"274","author":"Russell-Jones","year":"1998","journal-title":"Am J Physiol"},{"key":"2019041121352784800_R232","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2265.2008.03231.x","article-title":"Peroxisome proliferator-activated receptor \u03b3 agonism modifies the effects of growth hormone on lipolysis and insulin sensitivity.","volume":"69","author":"Krag","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R233","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-2265.1987.tb00805.x","article-title":"Acromegaly.","volume":"26","author":"Nabarro","year":"1987","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R234","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1210\/jcem-27-10-1418","article-title":"Changes of carbohydrate tolerance in acromegaly with progress of the disease and in response to treatment.","volume":"27","author":"Sonksen","year":"1967","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R235","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1210\/jc.2004-2009","article-title":"Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly.","volume":"90","author":"Puder","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R236","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a metaanalysis.","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R237","doi-asserted-by":"crossref","first-page":"E269","DOI":"10.1152\/ajpendo.1986.250.3.E269","article-title":"Insulin resistance in acromegaly: defects in both hepatic and extrahepatic insulin action","volume":"250","author":"Hansen","year":"1986","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2019041121352784800_R238","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1210\/jcem-72-5-1048","article-title":"Peripheral glucose metabolism in acromegaly.","volume":"72","author":"Foss","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R239","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2265.1985.tb00153.x","article-title":"Glucose tolerance and plasma immunoreactive insulin levels in acromegalics before and after selective transsphenoidal surgery.","volume":"22","author":"Roelfsema","year":"1985","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R240","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1046\/j.1365-2265.2000.00986.x","article-title":"Impaired \u03b2-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients.","volume":"52","author":"Kasayama","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R241","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1210\/jc.2003-030915","article-title":"Long-term biochemical status and disease-related morbidity in 53 postoperative patients with acromegaly.","volume":"89","author":"Serri","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R242","first-page":"3395","article-title":"Clinical review 75: recent advances in pathogenesis, diagnosis, and management of acromegaly.","volume":"80","author":"Melmed","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R243","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1530\/eje.1.02036","article-title":"Consensus statement: medical management of acromegaly.","volume":"153","author":"Melmed","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"2019041121352784800_R244","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1210\/jc.2003-031138","volume":"89","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R245","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1210\/jc.2002-011841","article-title":"Guidelines for acromegaly management.","volume":"87","author":"Melmed","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R246","first-page":"3534","article-title":"Acromegaly\u2014consensus, what consensus?","volume":"87","author":"Trainer","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R247","first-page":"526","article-title":"Criteria for cure of acromegaly: a consensus statement.","volume":"85","author":"Giustina","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R248","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1210\/jcem.83.2.4556","article-title":"Cabergoline in the treatment of acromegaly: a study in 64 patients.","volume":"83","author":"Abs","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R249","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1210\/jcem.82.2.3648","article-title":"Effect of different dopaminergic agents in the treatment of acromegaly.","volume":"82","author":"Colao","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R250","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0140-6736(73)92873-0","article-title":"Inhibition of insulin secretion by somatostatin.","volume":"2","author":"Alberti","year":"1973","journal-title":"Lancet"},{"key":"2019041121352784800_R251","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2265.1986.tb01663.x","article-title":"Effects of somatostatin analogue SMS 201\u2013995 in normal man.","volume":"24","author":"Davies","year":"1986","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R252","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0016-5085(80)90188-2","article-title":"Effect of intravenous somatostatin on jejunal absorption of glucose, amino acids, water, and electrolytes.","volume":"78","author":"Krejs","year":"1980","journal-title":"Gastroenterology"},{"key":"2019041121352784800_R253","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1042\/cs0750345","article-title":"Effects of the somatostatin analogue SMS 201\u2013995 (sandostatin) on mouth-to-caecum transit time and absorption of fat and carbohydrates in normal man.","volume":"75","author":"Moller","year":"1988","journal-title":"Clin Sci (Lond)"},{"key":"2019041121352784800_R254","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2337\/diab.36.5.673","article-title":"Somatostatin impairs clearance of exogenous insulin in humans.","volume":"36","author":"Ipp","year":"1987","journal-title":"Diabetes"},{"key":"2019041121352784800_R255","first-page":"1789","article-title":"Somatostatin enhances insulin-stimulated glucose uptake in the perfused human forearm.","volume":"80","author":"Moller","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R256","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2265.1992.tb01443.x","article-title":"Impact of octreotide, a long-acting somatostatin analogue, on glucose tolerance and insulin sensitivity in acromegaly.","volume":"36","author":"Ho","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R257","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1530\/eje.0.1300581","article-title":"Effect of octreotide on glucose tolerance in acromegaly.","volume":"130","author":"Koop","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"2019041121352784800_R258","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1046\/j.1365-2265.2003.01734.x","article-title":"Primary medical therapy for acromegaly.","volume":"58","author":"Sheppard","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R259","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1046\/j.1365-2265.2003.01876.x","article-title":"Glucose homeostasis in acromegaly: effects of long-acting somatostatin analogues treatment.","volume":"59","author":"Baldelli","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2019041121352784800_R260","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1210\/jc.2003-030110","article-title":"Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?","volume":"88","author":"Cozzi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R261","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/jc.2005-1704","article-title":"Comparison between six-year therapy with long-acting somatostatin analogs and successful surgery in acromegaly: effects on cardiovascular risk factors.","volume":"91","author":"Ronchi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R262","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1210\/er.2001-0022","article-title":"Growth hormone receptor antagonists: discovery, development, and use in patients with acromegaly.","volume":"23","author":"Kopchick","year":"2002","journal-title":"Endocr Rev"},{"key":"2019041121352784800_R263","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM200004203421604","article-title":"Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.","volume":"342","author":"Trainer","year":"2000","journal-title":"N Engl J Med"},{"key":"2019041121352784800_R264","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/S0140-6736(01)06844-1","article-title":"Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist.","volume":"358","author":"Lely","year":"2001","journal-title":"Lancet"},{"key":"2019041121352784800_R265","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1210\/jc.2005-0331","article-title":"Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant.","volume":"90","author":"Barkan","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R266","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S1096-6374(02)00083-7","article-title":"Growth hormone receptor antagonist improves insulin resistance in acromegaly.","volume":"12","author":"Rose","year":"2002","journal-title":"Growth Horm IGF Res"},{"key":"2019041121352784800_R267","doi-asserted-by":"crossref","first-page":"5627","DOI":"10.1210\/jc.2005-0531","article-title":"Cotreatment of acromegaly with a somatostatin analog and a growth hormone receptor antagonist.","volume":"90","author":"Jorgensen","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R268","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1530\/eje.0.1490521","article-title":"Insulin sensitivity and glucose tolerance improve in patients with acromegaly converted from depot octreotide to pegvisomant.","volume":"149","author":"Drake","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"2019041121352784800_R269","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1210\/jc.2006-2276","article-title":"The impact of pegvisomant treatment on substrate metabolism and insulin sensitivity in patients with acromegaly.","volume":"92","author":"Lindberg-Larsen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R270","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11102-007-0037-7","article-title":"Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA.","volume":"10","author":"De Marinis","year":"2007","journal-title":"Pituitary"},{"key":"2019041121352784800_R271","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1210\/jc.2002-020343","article-title":"IGF-I\/IGF-binding protein-3 combination improves insulin resistance by GH-dependent and independent mechanisms.","volume":"87","author":"O'Connell","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R272","first-page":"381","article-title":"Body composition and energy expenditure in acromegaly.","volume":"78","author":"O'Sullivan","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R273","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1172\/JCI102977","article-title":"Body water and sodium in patients with acromegaly.","volume":"33","author":"Ikkos","year":"1954","journal-title":"J Clin Invest"},{"key":"2019041121352784800_R274","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJM196201042660109","article-title":"Growth hormone. 1. Physiologic aspects.","volume":"266","author":"Raben","year":"1962","journal-title":"N Engl J Med"},{"key":"2019041121352784800_R275","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1056\/NEJM196201112660207","article-title":"Growth hormone. 2. Clinical use of human growth hormone.","volume":"266","author":"Raben","year":"1962","journal-title":"N Engl J Med"},{"key":"2019041121352784800_R276","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-146-2-200701160-00005","article-title":"Systematic review: the safety and efficacy of growth hormone in the healthy elderly.","volume":"146","author":"Liu","year":"2007","journal-title":"Ann Intern Med"},{"key":"2019041121352784800_R277","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1210\/jc.2008-1357","article-title":"Effects of recombinant human growth hormone therapy in obesity in adults: a metaanalysis.","volume":"94","author":"Mekala","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R278","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jc.2005-0957","article-title":"The effects of growth hormone and\/or testosterone in healthy elderly men: a randomized controlled trial.","volume":"91","author":"Giannoulis","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2019041121352784800_R279","doi-asserted-by":"crossref","first-page":"601","DOI":"10.7326\/0003-4819-149-9-200811040-00003","article-title":"Effects of an oral ghrelin mimetic on body composition and clinical outcomes in healthy older adults: a randomized trial.","volume":"149","author":"Nass","year":"2008","journal-title":"Ann Intern Med"},{"key":"2019041121352784800_R280","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1210\/er.2004-0019","article-title":"Development of growth hormone secretagogues.","volume":"26","author":"Smith","year":"2005","journal-title":"Endocr Rev"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/30\/2\/152\/10334545\/edrv0152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,19]],"date-time":"2019-05-19T05:24:33Z","timestamp":1558243473000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/edrv\/article\/30\/2\/152\/2355062"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,1]]},"references-count":280,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2008-0027","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,1]]}}}